NCT00004406
Completed
Not Applicable
Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
ConditionsOsteoporosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Osteoporosis
- Sponsor
- Columbia University
- Enrollment
- 36
- Locations
- 1
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
OBJECTIVES:
I. Determine the effect of human parathyroid hormone (1-34) on bone mass in middle-aged men with idiopathic osteoporosis.
Detailed Description
PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled study. All patients self-administer daily subcutaneous injections of human parathyroid hormone (1-34) or placebo for a period of 2.5 years. Patients are followed regularly for unacceptable toxicities. Completion date provided represents the completion date of the grant per OOPD records
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Impact of Parathyroid Hormone (PTH) on Osseous CavityBone LossPeriodontitisNCT00277706University of Michigan40
Completed
Phase 2
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal WomenPostmenopausal OsteoporosisOsteoporosisNCT00086619Massachusetts General Hospital80
Withdrawn
Phase 1
One Week Comparison Study of PTH and PTHrP InfusionsOsteoporosisHypercalcemia of MalignancyHyperparathyroidismBone Diseases, EndocrineNCT01333267University of Pittsburgh
Not yet recruiting
Not Applicable
The Bone-parathyroid Crosstalk in Primary HyperparathyroidismHyperparathyroidism, PrimaryOsteoporosisParathyroid NeoplasmsNCT05556499I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio100
Completed
Phase 2
Bone Properties in Hypoparathyroidism: Effects of PTHHypoparathyroidismNCT00473265John P. Bilezikian68